LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 81.05 | 84.90 | 9508 | 8863 | 1.0727 | 1.0210 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 81.05 | 84.90 | 935 | 8863 | 0.1055 | 0.4301 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 81.05 | 84.90 | 10841 | 8863 | 1.2230 | 1.0610 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.75 | 84.90 | 5836 | 8621 | 0.6769 | 0.8863 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.75 | 84.90 | 9583 | 8621 | 1.1115 | 1.0320 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.75 | 84.90 | 995 | 8621 | 0.1154 | 0.4466 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.75 | 84.90 | 10987 | 8621 | 1.2744 | 1.0741 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 84.45 | 84.90 | 5684 | 8254 | 0.6886 | 0.8901 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 84.45 | 84.90 | 9696 | 8254 | 1.1746 | 1.0493 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 84.45 | 84.90 | 974 | 8254 | 0.1180 | 0.4470 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 84.45 | 84.90 | 11261 | 8254 | 1.3642 | 1.0963 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 86.16 | 84.90 | 5509 | 8141 | 0.6766 | 0.8848 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 86.16 | 84.90 | 9786 | 8141 | 1.2019 | 1.0567 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 86.16 | 84.90 | 962 | 8141 | 0.1182 | 0.4459 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 86.16 | 84.90 | 11464 | 8141 | 1.4080 | 1.1067 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.86 | 84.90 | 4615 | 7680 | 0.6009 | 0.8492 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.86 | 84.90 | 9881 | 7680 | 1.2865 | 1.0791 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.86 | 84.90 | 898 | 7680 | 0.1169 | 0.4375 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.86 | 84.90 | 11644 | 7680 | 1.5161 | 1.1322 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 89.57 | 84.90 | 4303 | 7494 | 0.5742 | 0.8355 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 89.57 | 84.90 | 10015 | 7494 | 1.3363 | 1.0917 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 89.57 | 84.90 | 1046 | 7494 | 0.1396 | 0.4748 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 89.57 | 84.90 | 11964 | 7494 | 1.5963 | 1.1501 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 91.27 | 84.90 | 4027 | 7420 | 0.5427 | 0.8192 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 91.27 | 84.90 | 10125 | 7420 | 1.3645 | 1.0987 | MN20160318_Q02 | H11 |